Olema Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US68062P1066

SecurityOLMA / Olema Pharmaceuticals, Inc.
InsiderCyrus Harmon
This page shows the track record and history of Harmon Cyrus insider trades in Olema Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Cyrus Harmon in OLMA / Olema Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OLMA / Olema Pharmaceuticals, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Cyrus Harmon in OLMA / Olema Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-09-18 10,000 8.3300 10,000 8.3300 83,300 1 8.1700 -1,600 -1.92
2025-09-18 3,086 8.3200 3,086 8.3200 25,676
2025-09-16 10,000 8.0400 10,000 8.0400 80,400
2025-09-16 1,914 8.0800 1,914 8.0800 15,465
2024-12-11 7,958 8.6600 7,958 8.6600 68,916
2024-12-11 179 9.3900 179 9.3900 1,681
2024-12-10 8,256 9.3700 8,256 9.3700 77,359
2023-11-22 3,989 13.9000 3,989 13.9000 55,447
2023-11-21 4,192 14.8600 4,192 14.8600 62,293
2023-06-08 10,000 6.3000 10,000 6.3000 63,000
2023-06-06 5,000 6.2950 5,000 6.2950 31,475
2023-06-05 5,000 6.0450 5,000 6.0450 30,225

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OLMA / Olema Pharmaceuticals, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-18 2025-09-18 4 Harmon Cyrus OLMA Common Stock S - Sale I 8.3200 -3,086 -26 117,028
2025-09-18 2025-09-18 4 Harmon Cyrus OLMA Common Stock S - Sale D 8.3300 -10,000 -83 744,140
2025-09-18 2025-09-16 4 Harmon Cyrus OLMA Common Stock S - Sale I 8.0800 -1,914 -15 120,114
2025-09-18 2025-09-16 4 Harmon Cyrus OLMA Common Stock S - Sale D 8.0400 -10,000 -80 754,140
2024-12-11 2024-12-11 4 Harmon Cyrus OLMA Common Stock S - Sale D 9.3900 -179 -2 764,140
2024-12-11 2024-12-11 4 Harmon Cyrus OLMA Common Stock S - Sale D 8.6600 -7,958 -69 764,319
2024-12-11 2024-12-10 4 Harmon Cyrus OLMA Common Stock S - Sale D 9.3700 -8,256 -77 772,277
2024-12-11 2024-12-09 4 Harmon Cyrus OLMA Common Stock A - Award D 29,250 780,533
2024-07-31 2024-07-30 4 Harmon Cyrus OLMA Common Stock S - Sale D 15.5500 -934 -15 751,283
2024-07-31 2024-07-29 4 Harmon Cyrus OLMA Common Stock S - Sale D 15.5800 -4,066 -63 752,217
2024-07-12 2024-07-11 4 Harmon Cyrus OLMA Common Stock S - Sale D 12.2600 -5,000 -61 756,283
2024-07-02 2024-06-28 4 Harmon Cyrus OLMA Common Stock S - Sale D 10.7700 -20,000 -215 761,283
2024-06-04 2024-06-04 4 Harmon Cyrus OLMA Common Stock S - Sale D 12.3300 -5,000 -62 781,283
2024-06-04 2024-06-03 4 Harmon Cyrus OLMA Common Stock S - Sale D 10.9300 -5,000 -55 786,283
2024-06-04 2024-05-31 4 Harmon Cyrus OLMA Common Stock S - Sale D 9.4100 -15,000 -141 791,283
2024-05-07 2024-05-06 4 Harmon Cyrus OLMA Common Stock S - Sale D 10.9200 -5,000 -55 806,283
2024-05-02 2024-04-30 4 Harmon Cyrus OLMA Common Stock S - Sale D 9.5100 -15,000 -143 811,283
2024-03-29 2024-03-28 4 Harmon Cyrus OLMA Common Stock S - Sale D 10.9700 -20,000 -219 826,283
2024-03-04 2024-02-29 4 Harmon Cyrus OLMA Common Stock S - Sale D 13.0000 -100 -1 846,283
2024-03-04 2024-02-29 4 Harmon Cyrus OLMA Common Stock S - Sale D 12.4100 -24,900 -309 846,383
2024-02-02 2024-02-01 4 Harmon Cyrus OLMA Common Stock S - Sale D 15.5600 -5,000 -78 871,283
2024-02-02 2024-01-31 4 Harmon Cyrus OLMA Common Stock S - Sale D 12.2300 -25,000 -306 876,283
2024-01-02 2023-12-29 4 Harmon Cyrus OLMA Common Stock S - Sale D 14.1000 -2,500 -35 901,283
2024-01-02 2023-12-29 4 Harmon Cyrus OLMA Common Stock S - Sale D 13.3000 -22,500 -299 903,783
2023-12-01 2023-11-30 4 Harmon Cyrus OLMA Common Stock S - Sale D 12.5700 -25,000 -314 926,283
2023-11-22 2023-11-22 4 Harmon Cyrus OLMA Common Stock S - Sale D 13.9000 -3,989 -55 951,283
2023-11-22 2023-11-21 4 Harmon Cyrus OLMA Common Stock S - Sale D 14.8600 -4,192 -62 955,272
2023-11-22 2023-11-20 4 Harmon Cyrus OLMA Common Stock A - Award D 15,750 959,464
2023-11-02 2023-11-02 4 Harmon Cyrus OLMA Common Stock S - Sale D 15.6400 -5,000 -78 943,714
2023-11-02 2023-10-31 4 Harmon Cyrus OLMA Common Stock S - Sale D 12.0500 -25,000 -301 948,714
2023-10-03 2023-09-29 4 Harmon Cyrus OLMA Common Stock S - Sale D 12.4100 -25,000 -310 973,714
2023-09-05 2023-08-16 4/A Harmon Cyrus OLMA Common Stock S - Sale D 10.1400 -15,000 -152 1,023,714
2023-09-05 2023-09-05 4 Harmon Cyrus OLMA Common Stock S - Sale D 11.6200 -10,000 -116 998,714
2023-09-05 2023-08-31 4 Harmon Cyrus OLMA Common Stock S - Sale D 9.3600 -15,000 -140 1,008,714
2023-08-17 2023-08-16 4 Harmon Cyrus OLMA Common Stock S - Sale D 10.1400 -15,000 -152 1,023,714
2023-06-09 2023-06-08 4 Harmon Cyrus OLMA Common Stock S - Sale D 6.3000 -10,000 -63 1,038,714
2023-06-07 2023-06-06 4 Harmon Cyrus OLMA Common Stock S - Sale D 6.2950 -5,000 -31 1,048,714
2023-06-07 2023-06-05 4 Harmon Cyrus OLMA Common Stock S - Sale D 6.0450 -5,000 -30 1,053,714
2022-02-03 2022-02-01 4 Harmon Cyrus OLMA Stock Option (Right to Buy) A - Award D 7.02 104,500 104,500
2021-12-01 2021-11-29 4 Harmon Cyrus OLMA Common Stock S - Sale D 24.7600 -400 -10 1,051,146
2021-10-21 2021-10-19 4 Harmon Cyrus OLMA Common Stock S - Sale D 28.2000 -4,555 -128 1,051,546
2021-10-21 2021-10-19 4 Harmon Cyrus OLMA Common Stock S - Sale D 27.8500 -7,445 -207 1,056,101
2021-09-21 2021-09-20 4 Harmon Cyrus OLMA Common Stock S - Sale D 26.3000 -12,000 -316 1,063,546
2021-08-20 2021-08-19 4 Harmon Cyrus OLMA Common Stock S - Sale D 24.9700 -12,000 -300 1,075,546
2021-07-21 2021-07-20 4 Harmon Cyrus OLMA Common Stock S - Sale D 25.6300 -4,123 -106 1,087,546
2021-07-21 2021-07-19 4 Harmon Cyrus OLMA Common Stock S - Sale D 24.8300 -7,877 -196 1,091,669
2021-06-21 2021-06-18 4 Harmon Cyrus OLMA Common Stock S - Sale D 26.3000 -600 -16 1,099,546
2021-06-21 2021-06-18 4 Harmon Cyrus OLMA Common Stock S - Sale D 25.5900 -1,990 -51 1,100,146
2021-06-21 2021-06-18 4 Harmon Cyrus OLMA Common Stock S - Sale D 24.5400 -9,410 -231 1,102,136
2020-11-23 2020-11-23 4 Harmon Cyrus OLMA Series A Convertible Preferred Stock C - Conversion I -122,028 0
2020-11-23 2020-11-23 4 Harmon Cyrus OLMA Series A Convertible Preferred Stock C - Conversion D -71,374 0
2020-11-23 2020-11-23 4 Harmon Cyrus OLMA Common Stock C - Conversion I 122,028 122,028
2020-11-23 2020-11-23 4 Harmon Cyrus OLMA Common Stock C - Conversion D 71,374 1,111,546
2020-11-19 2020-11-18 4 Harmon Cyrus OLMA Stock Option (Right to Buy) A - Award D 19.00 179,340 179,340
2020-11-19 2020-09-12 4 Harmon Cyrus OLMA Stock Option (Right to Buy) A - Award D 4.82 227,859 227,859
2020-11-19 2020-06-15 4 Harmon Cyrus OLMA Common Stock A - Award D 143,472 1,040,172
2020-11-18 3 Harmon Cyrus OLMA Common Stock D 1,040,172
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)